Treatment with an oral capsule containing the spores of approximately 50 species of beneficial bacteria successfully prevented recurrence of C. difficile infection in patients with a history of ...
Results from a Phase 1b/2 trial suggest that an investigational microbiome-based, oral therapeutic drug is effective for the treatment of recurrent C. difficile infection. In a paper published online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback